Zydus Wellness Limited has released a revised investor presentation for its Analyst/Institutional Investors' Conference scheduled on March 18-19, 2026. Company Secretary and Compliance Officer Nandish P. Joshi informed BSE and NSE through a regulatory filing, pursuant to Regulation 30 of SEBI Listing Regulations.

Regulatory Compliance and Presentation Updates

The revised presentation follows the company's earlier intimation dated March 16, 2026, and has been uploaded on the company's website at www.zyduswellness.com in compliance with Regulation 46(2)(o)(ii) of the Listing Regulations. The presentation includes comprehensive portfolio performance data and strategic initiatives across the company's brand portfolio.

Financial Performance Overview

The presentation highlights strong financial metrics with the company maintaining robust gross margins across quarters. Recent performance shows consistent revenue growth with PAT margins ranging between 11.50% to 15.40% across different periods.

Infrastructure and Market Reach

Zydus Wellness operates with significant market presence, serving over 70 million families through approximately 2.80 million stores. The company maintains a robust distribution network with 1,950+ distributors and 2,500+ feet-on-street representatives, reaching around 0.70 million direct customers.

Brand Portfolio Performance

The presentation showcases strong performance across key brands including Sugar Free, Complan, Everyuth, and Nycil. Complan has improved its market ranking to fourth position with 4.10% market share, while Everyuth achieved double-digit growth in YTD FY26.

Key Brand Developments:

• Sugar Free and I'm lite continue shaping the everyday wellness segment
• TAN Removal segment showing strong growth with D-Tan Facewash launch
• Nycil maintains leadership in prickly heat powder category with 100% consumer awareness
• RiteBite Max Protein expanded to nine international markets
• Glucon-D entered performance hydration with GD Activon

Strategic Initiatives and Innovation

The company focuses on innovation-led interventions across its portfolio. The presentation emphasizes building lifelong consumer relationships through focused innovation and strong B2B/B2C execution. Recent launches include 9 new products, with continued expansion in international markets across Bahrain, Bangladesh, UAE, Malaysia, United Kingdom, Germany, Australia, and various African nations.

The revised investor presentation provides comprehensive insights into the company's strategic direction, portfolio performance, and growth initiatives across domestic and international markets, reinforcing Zydus Wellness's position in the consumer wellness segment.

Zydus Wellness Limited has disclosed multiple equity share acquisitions by designated persons under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Three designated persons - Mr. Vineet Shrivastava, Mr. Yatin Desai, and Mr. Rajat Bhargava - acquired a total of 2,037 equity shares from the open market between March 2-6, 2026.

Transaction Overview

The share acquisitions were executed on NSE with specific financial parameters outlined in the regulatory disclosures. The transactions represent a combined investment of ₹7,77,935.55 by the three designated persons, with each equity share having a face value of ₹2/-.

Individual Shareholding Impact

The transactions show varying impacts on individual shareholding positions. Mr. Vineet Shrivastava increased his holdings from 507 shares to 1,294 shares, while Mr. Yatin Desai's holdings grew from 25 shares to 525 shares. Mr. Rajat Bhargava acquired his first equity position in the company with 750 shares.

Regulatory Compliance

The disclosures were made in accordance with Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Zydus Wellness Limited submitted the prescribed Form "B" to both BSE Limited and National Stock Exchange of India Limited on March 9, 2026. The company secretary and compliance officer, Nandish P. Joshi, signed the disclosure document digitally.

Designated Persons Profile

All three designated persons are associated with Zydus Wellness Limited's organizational structure and are based at the company's corporate office at Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, S. G. Highway, Ahmedabad – 382481, Gujarat. The disclosures confirm that no derivative trading activities were undertaken by any of the designated persons in connection with these transactions, as indicated by the "N.A." entries in the derivatives trading sections of the regulatory forms.